13 Spam-Free Article(s) Found
Sort:
Like
Filter:
All
Article Searches
Incyte to Test Its Cancer Drug Jakafi as a Treatment for COVID-19 https://www.fool.com/investing/2020/04/02/incyte-to-test-its-cancer-drug-jakafi-as-a-treatme.aspx?source=iedfolrf0000001 Apr 02, 2020 - Both diseases involve an overactive immune system.
Incyte to Evaluate Lead Drug Jakafi for COVID-19 Infection http://www.zacks.com/stock/news/852806/incyte-to-evaluate-lead-drug-jakafi-for-covid-19-infection?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-852806 Apr 03, 2020 - Incyte (INCY) plans to work with the FDA for evaluating Jakafi in patients with COVID-19-associated cytokine storm.
Biotech Stock Roundup: AMGN & INCY Focus on Coronavirus Treatments, & More http://www.zacks.com/stock/news/860777/biotech-stock-roundup-amgn-incy-focus-on-coronavirus-treatments-more?cid=CS-ZC-FT-analyst_blog|stock_roundup-860777 Apr 08, 2020 - The biotech sector is in focus with pipeline updates from companies evaluating treatments for the novel COVID-19.
Bausch (BHC) Starts Study on Virazole for Coronavirus Infection http://www.zacks.com/stock/news/870392/bausch-bhc-starts-study-on-virazole-for-coronavirus-infection?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-870392 Apr 14, 2020 - Bausch (BHC) begins a clinical study on Virazole in combination with standard-of-care therapy to treat adults with respiratory distress due to COVID-19 in Canada.
Novartis To Initiate Hydroxychloroquine Study for Coronavirus http://www.zacks.com/stock/news/880449/novartis-to-initiate-hydroxychloroquine-study-for-coronavirus?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-880449 Apr 20, 2020 - Novartis (NVS) announces FDA's approval to evaluate hydroxychloroquine in hospitalized patients with COVID-19 in a late-stage study. The company is evaluating several of its drugs to treat COVID-19.
Analysts Estimate Incyte (INCY) to Report a Decline in Earnings: What to Look Out for http://www.zacks.com/stock/news/896061/analysts-estimate-incyte-incy-to-report-a-decline-in-earnings-what-to-look-out-for?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_9-896061 Apr 28, 2020 - Incyte (INCY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Biotech Stocks, ETFs to Gain on COVID-19 Vaccine & Drug Progress http://www.zacks.com/stock/news/859545/biotech-stocks-etfs-to-gain-on-covid-19-vaccine-drug-progress?cid=CS-ZC-FT-etf_news_and_commentary-859545 Apr 07, 2020 - The race to introduce a vaccine and drug for COVID-19 is creating near-term opportunities, making the biotech sector a lucrative space for investments.
Vanda Begins Enrollment in Study for Severe Coronavirus Infection http://www.zacks.com/stock/news/874470/vanda-begins-enrollment-in-study-for-severe-coronavirus-infection?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-874470 Apr 16, 2020 - Vanda (VNDA) and The Feinstein Institutes for Medical Research initiate enrollment in the phase III ODYSSEY study on tradipitant to treat inflammatory lung injury associated with COVID-19 infection.
Gilead's (GILD) Coronavirus Drug Shows Promise, Shares Gain http://www.zacks.com/stock/news/876070/gileads-gild-coronavirus-drug-shows-promise-shares-gain?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-876070 Apr 17, 2020 - Treatment with Gilead's (GILD) experimental antiviral, remdesivir, shows rapid recoveries in fever and respiratory symptoms in COVID-19 patients in a Chicago hospital.
Roche's New Test to Detect Antibodies to Fight Coronavirus http://www.zacks.com/stock/news/876409/roches-new-test-to-detect-antibodies-to-fight-coronavirus?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-876409 Apr 17, 2020 - Roche (RHHBY) develops Elecsys, a new serology test, for the detection of antibodies against SARS-CoV-2, the virus causing COVID-19. The company plans to launch the same early next month.

Pages: 12

Page 1